American Association for Cancer Research (AACR) Annual Meeting
Sunday, April 2, 2017
Walter E. Washington Convention Center
Session DDT01 - New Drugs on the Horizon 1
East Salon A-B, Level 1, Washington Convention Center
Time: 2:30 – 3:00 p.m.
Title: Durable efficacy and anticancer immunity following intratumoral administration of a combination of messenger RNAs encoding the costimulatory molecule OX40L and the cytokines IL-36g and IL-23
Speaker: Josh Frederick, Ph.D.
Head of Onkaido Research
Onkaido, a Moderna Venture